Specialty Drug Spend Management: Tackling the 5% of Members Driving 50% of Rx Costs

Understanding Specialty Drug Spending

Specialty drugs account for a disproportionate share of total pharmacy costs. According to the 2023 Aon Health Value Insights report, specialty medications represent approximately 50% of total pharmacy spending while only being prescribed to about 5% of members. This stark contrast underscores the urgent need for self-insured employers to implement effective strategies for managing these costs.

The Financial Impact of Specialty Drugs

To put the financial dynamics into perspective:

• Total U.S. Prescription Drug Spending: $500 billion
• Specialty Drug Spending: Approximately $250 billion
• Average Cost of Specialty Drugs: Ranges from $2,000 to over $100,000 per month depending on the medication.

Given that the average employer spends about $1,200 per employee annually on prescription drugs, the impact of specialty drugs can quickly escalate. For an employer with 1,000 employees, this can mean a direct cost of up to $600,000 annually, just from the specialty medications affecting the top 5% of their workforce.

Identifying Key Drivers of Specialty Drug Costs

Several factors contribute to the rising costs of specialty drugs:

• Chronic Conditions: Members with chronic conditions often require specialty medications. Conditions such as cancer, rheumatoid arthritis, and multiple sclerosis are common culprits.
• High Price Tags: The average annual cost of a specialty drug is now $70,000, compared to just $3,000 for traditional medications.
• Limited Alternatives: Many specialty drugs do not have generic alternatives, leading to higher prices.

Who Are the High-Cost Members?

Understanding which members are contributing to the high costs is essential. Typically, the high-cost 5% are:

• Members with multiple chronic conditions.
• Those who recently started a new specialty medication.
• Patients transitioning from traditional therapies to specialty drugs due to a lack of efficacy.

Strategies for Containing Specialty Drug Costs

Employers can implement several effective strategies to manage specialty drug spending, which can yield significant savings.

1. Specialty Pharmacy Networks

Utilizing a specialized pharmacy network can help manage costs by:

• Negotiating better prices with manufacturers.
• Providing better patient management support.
• Offering higher adherence rates, which leads to better health outcomes and lower total costs.

2. Prior Authorization Requirements

Implementing prior authorization ensures that:

• Only necessary specialty medications are prescribed.
• Cost-effective alternatives are considered before approving expensive treatments.

Data from the National Pharmacy Benefits Manager Association shows that prior authorization can reduce specialty drug spending by up to 20%.

3. Patient Assistance Programs

These programs can reduce out-of-pocket costs for employees while providing the following benefits:

• Access to low-cost medications.
• Support for navigating insurance coverage.

Employers can collaborate with drug manufacturers to facilitate these programs, ensuring that employees maximize available support.

4. Implementing a Condition Management Program

By focusing on chronic conditions that require specialty drugs, employers can:

• Provide outreach and education to members.
• Improve health outcomes, which reduces overall costs.

For instance, a robust condition management program can result in a 30% reduction in specialty drug spend according to studies by the Employee Benefit Research Institute.

5. Data Analytics for Predictive Modeling

Employers can leverage data analytics to:

• Identify members at risk of high specialty drug costs before they become high spenders.
• Tailor interventions to specific populations based on predictive models, thus preventing costs from escalating.

Bottom Line

Specialty drugs represent a critical area for cost containment for self-insured employers. By focusing on the 5% of members driving 50% of prescription costs, employers can implement targeted strategies that include specialty pharmacy networks, prior authorization, patient assistance programs, condition management, and data analytics. Addressing these high-cost medications directly can lead to more sustainable pharmacy spending and improved health outcomes for employees.

Employers should actively monitor their specialty drug utilization and costs, ensuring they have the necessary tools and strategies in place to contain this growing expense.